Other Clinical Trial - Safety & Initial Efficacy Study of the Vortx Rx for

See also
Status	Clinical Trial	Phase
Completed	`NCT03052049` - Prostatic Artery Embolization (PAE) for Treatment of Signs and Symptoms of Benign Prostatic Hyperplasia (BPH) Using Bead Block Microspheres	N/A
Recruiting	`NCT04757116` - Post-Market Study to Assess iTind Safety in Comparison to UroLift	N/A
Completed	`NCT03460873` - Prognostic Factor in the Patients With Benign Prostatic Hyperplasia Who Undergo Holmium Laser Enucleation of the Prostate
Completed	`NCT01218243` - An Efficacy Trial of Electroacupuncture at Points of Bilateral BL33 for Mild and Moderate Benign Prostatic Hyperplasia	Phase 2
Completed	`NCT01566292` - Intraprostatic Botulinum Toxin Type "A" Injection in Patients With Benign Prostatic Hyperplasia and Unsatisfactory Response to Medical Therapy	Phase 2/Phase 3
Active, not recruiting	`NCT00407953` - PROLIEVE® Post-Marketing Study TREATMENT OF BENIGN PROSTATIC HYPERPLASIA (BPH)	Phase 4
Completed	`NCT03191734` - French Aquablation Clinical Investigation Using Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue	N/A
Recruiting	`NCT04838769` - REZŪM vs. Dual Drug Therapy for Symptomatic Benign Prostatic Hyperplasia in Sexually Active Men	N/A
Completed	`NCT03856242` - Benign Prostatic Hyperplasia and Ischemic Heart DIsease	Phase 4
Completed	`NCT04032067` - Evaluate the Efficacy and Safety of GV1001 in Patients With Benign Prostatic Hyperplasia (BPH)	Phase 3
Completed	`NCT02505919` - Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER)	N/A
Completed	`NCT02855892` - A Phase II Clinical Trial to Evaluate the Efficacy and Safety of GV1001 in Patients With BPH	Phase 2
Completed	`NCT02145208` - Study to Assess the Efficacy of Medi-Tate iTind Device	N/A
Completed	`NCT00970632` - A Study of Tadalafil in Men With Benign Prostatic Hyperplasia	Phase 3
Recruiting	`NCT02592473` - Prostate Artery Embolization (PAE) for Treatment of Benign Prostatic Hyperplasia	N/A
Completed	`NCT00945490` - Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018	Phase 3
Completed	`NCT00759135` - Phase 2 Study of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) (Enlarged Prostate)	Phase 2
Completed	`NCT00224107` - A New Drug for Benign Prostatic Hyperplasia (BPH) Compared With Placebo	Phase 3
Recruiting	`NCT04648176` - Application of MOSES Technology in BPH	N/A
Terminated	`NCT00651807` - A Trial to Investigate the Effectiveness and Safety of Org 3236 (Etonogestrel) Tablets in Men With Urinary Complaints Suggestive of a Benign Enlargement of the Prostate (304001)(P05806)	Phase 2

NCT number	NCT01896973
Study type	Interventional
Source	HistoSonics, Inc.
Contact
Status	Terminated
Phase	N/A
Start date	July 2013
Completion date	December 2016

Safety and Initial Efficacy Study of the Vortx Rx for Treatment of Benign Prostatic Hyperplasia (US)

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms